MRNA Jan 2024 125.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:57PM EST. Market open.
| Previous close | 79.20 |
| Open | 79.26 |
| Bid | 72.90 |
| Ask | 74.30 |
| Strike | 125.00 |
| Expiry date | 2024-01-19 |
| Day's range | 79.20 - 79.26 |
| Contract range | N/A |
| Volume | |
| Open interest | 218 |
- Zacks
Pfizer (PFE) Seeks FDA Nod for Bivalent COVID Jab in Infants
Pfizer (PFE) and partner BioNTech seek label expansion to use their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in young children under five years.
- Simply Wall St.
Moderna (NASDAQ:MRNA) shareholders have earned a 111% CAGR over the last three years
Investing can be hard but the potential fo an individual stock to pay off big time inspires us. You won't get it right...
- Zacks
Should Investors Buy Pfizer (PFE) & Moderna (MRNA) Stock for 2023?
Much of the social and economic post-pandemic recovery is accredited to Covid-19 vaccine makers Pfizer (PFE) and Moderna (MRNA). Investors may be wondering if these stocks will continue to be strong investments going into 2023.
© 2022 Yahoo. All rights reserved.
